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Abstract 
AIM: To investigate collagen patches seeded with 
mesenchymal stem cells (MSCs) and/or tenocytes (TCs) 
with regards to their suitability for anterior cruciate 
ligament (ACL) repair. 
METHODS: Dynamic intraligamentary stabilization 
utilizes a dynamic screw system to keep ACL remnants 
in place and promote biological healing, supplemented 
by collagen patches. How these scaffolds interact with 
cells and what type of benefit they provide has not yet 
been investigated in detail. Primary ACL-derived TCs 
and human bone marrow derived MSCs were seeded 
onto two different types of 3D collagen scaffolds, 
Chondro-Gide® (CG) and Novocart® (NC). Cells were 
seeded onto the scaffolds and cultured for 7 d either 
as a pure populations or as “premix” containing a 1:1 
ratio of TCs to MSCs. Additionally, as controls, cells were 
seeded in monolayers and in co-cultures on both sides 
of porous high-density membrane inserts (0.4 µm). We 
analyzed the patches by real time polymerase chain 
reaction, glycosaminoglycan (GAG), DNA and hydroxy-
proline (HYP) content. To determine cell spreading 
and adherence in the scaffolds microscopic imaging 
techniques, i.e. , confocal laser scanning microscopy 
(cLSM) and scanning electron microscopy (SEM), were 
applied.
RESULTS: CLSM and SEM imaging analysis confirmed 
cell adherence onto scaffolds. The metabolic cell 
activity revealed that patches promote adherence 
and proliferation of cells. The most dramatic increase 
in absolute metabolic cell activity was measured 
for CG samples seeded with tenocytes or a 1:1 cell 
premix. Analysis of DNA content and cLSM imaging 
also indicated MSCs were not proliferating as nicely as 
tenocytes on CG. The HYP to GAG ratio significantly 
changed for the premix group, resulting from a slightly 
lower GAG content, demonstrating that the cells are 
modifying the underlying matrix. Real-time quantitative 
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polymerase chain reaction data indicated that MSCs 
showed a trend of differentiation towards a more 
tenogenic-like phenotype after 7 d. 
CONCLUSION: CG and NC are both cyto-compatible 
with primary MSCs and TCs; TCs seemed to perform 
better on these collagen patches than MSCs.
Key words: Anterior cruciate ligament rupture; Anterior 
cruciate ligament tenocyte; Dynamic intraligamentary 
stabilization system; Resazurin red assay; Mesenchymal 
stem cells; Real-time polymerase chain reaction; 
Histology; Scanning electron microscopy microscopy; 
Scanning electron microscopy
© The Author(s) 2015. Published by Baishideng Publishing 
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Core tip: Commercially available porcine or bovine-
derived collagen type Ⅰ and type Ⅲ patches are 
cytocompatible for anterior cruciate ligament derived 
tenocytes (ACL-TCs) and for bone-marrow derived 
mesenchymal stem cells (MSCs). The combination of 
commercially available collagen patches with MSCs 
and ACL-TCs seems to be suitable for application with 
a dynamic intraligamentary stabilization system, which 
represents a novel technique to fix a ruptured ACL. 
However, co-culture of MSCs with ACL-TCs did show 
signs of differentiation of MSCs towards a more TC-like 
phenotype after a short-term culture of 7 d.
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INTRODUCTION
Anterior cruciate ligament (ACL) injuries represent 
one of the most common ligament injuries, estimated 
to impact 100000 to 200000 people annually in the 
United States[1-4]. In Germany, the incidence of ACL 
ruptures is estimated at 32 per 100000 in the general 
population; in the active sports community, this rate 
is more than twice as high, at 70 per 100000[1]. The 
ACL provides an essential mechanism for ensuring 
stability in the knee joint[5]. The instability resulting 
from ACL injury not only impairs the functionality of 
the joint, but can also result in secondary damage 
to other structures, leading to arthritic changes[1,6,7]. 
Current surgical treatment methods are thus focused 
on restoring stability of the knee, reducing pain and 
preventing osteoarthritis[1,8,9]. The cruciate ligaments 
do not heal spontaneously; this has been attributed to 
a lack of a fibrin-platelet clot formation in ACL defects, 
which may be due to the synovial fluid surrounding the 
cruciate ligaments into which blood from the ruptured 
stumps disperses, as well as to high levels of plasmin 
concentrations known to be circulating in the synovial 
fluid[10]. Lack of spontaneous healing necessitates 
intervention to provide for alternative options to 
restore stability.
Given the clinical success of the dynamic intra-
ligamentary stabilization approach in ACL repair[11-13], the 
aim of this study was to provide insight as to whether 
the collagen patches-which are currently approved 
and marketed for cartilage and meniscus repair–are 
also suitable for ACL repair, and elucidate the extent 
to which they impact and interact with cells. For this 
purpose, we tested two commercially available collagen 
scaffolds with regards to cell viability, adherence and 
proliferation of seeded tenocytes (TCs), the primary 
cell type in ACL tissue[14]. TCs are considered to be a 
specific subset of the category of fibroblasts[14]. Ideally, 
the cells seeded on the scaffold would proliferate and 
modify the matrix, slowly reconstructing the original 
tissue. 
Considering the difficulty of obtaining autologous 
ACL-derived TCs for common surgical use, we also 
used bone-marrow derived mesenchymal stem 
cells (MSCs), which can be easily harvested through 
bone marrow aspiration, cultured and stimulated 
to differentiate into a fibroblast phenotype[2,6,15]. 
Several studies propose MSCs proliferate faster than 
TCs, and also exhibit a higher survivability in vivo[15]. 
Additionally, current literature suggests that MSCs 
may have an anti-inflammatory effect, providing an 
additional benefit for their use in tissue engineering[16]. 
We were particularly interested whether the MSCs 
would be able to stimulate the TCs in this in vitro 
experiment set up.
Due to the composition of the scaffold materials, we 
hypothesized that the patches would provide a suitable 
environment for TCs and lead to cell adherence 
as well as proliferation and collagen deposition. 
Furthermore, we expected MSCs to differentiate into 
a TCs phenotype in co-culture and even more so if 
cultured on collagen scaffolds rather than cultured on 
culture inserts. Currently, no unique marker profile for 
ligaments exists; thus, tendon-like cells are commonly 
distinguished using a combination of markers, including 
scleraxis, tenomodulin, tenascin-C, collagen Ⅰand 
collagen Ⅲ[6,14]. 
Here, we present analyses on cell compatibility for 
primary ACL-derived TCs and bone-marrow derived 
MSCs seeded on collagen scaffolds. We investigated 
the phenotype of these cells using real time real time 
polymerase chain reaction (RT-PCR) and biochemical 
analysis in order to judge the suitability of cell-seeded 
collagen scaffolds for the Ligamys surgery application 
to “boost” the healing process and possibly to improve 
the surgery’s outcome. To the best of our knowledge, 
no studies have been previously published with this 
aim. 
Gantenbein B et al . Mesenchymal stem cells for ACL repair
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MATERIALS AND METHODS
Scaffolds and sample preparation
Two types of commercially available and CE label 
approved bio-resorbable collagen scaffolds were 
tested in the experiments: Novocart© (NC) produced 
by Tetec AG (Reutlingen, Germany), a B. Braun AG 
Company, and Chondro-Gide© (CG), produced by 
Geistlich Pharma AG (Wolhusen, Switzerland). NC is a 
biphasic collagen-chondroitin sulfate matrix of bovine 
origin; CG represents a porcine collagen bilayer matrix. 
Both scaffolds were specifically developed for human 
chondrocytes and are used clinically in connection 
with autologous chondrocyte transplantation and 
autologous matrix-induced chondrogenesis for cartilage 
regeneration. Here, we investigated these scaffolds 
for application in ACL repair (Figures 1 and 2). The NC 
and CG scaffolds comprise a porous sponge and an 
adhering compact membrane to protect the cells and 
the lesion. Cells were seeded on the porous side as 
intended by its application. The sponge itself consists 
of fibers, building a three-dimensional structure with 
interconnecting pores.
Prior to cell seeding, the scaffolds were cut in equally 
sized samples using an 8 mm sterile biopsy punch (Kai 
Medical, Polymed Inc., Glattbrugg, Switzerland) and 
then soaked in high glucose Dulbecco’s Modified Eagle’
s Medium (HG-DMEM), (Gibco, Life Technologies, Zug, 
Switzerland) with 10% fetal calf serum (FCS) and 1 × 
penicillin-streptomycin (P/S) (all Sigma-Aldrich, Buchs, 
Switzerland). The patches were seeded with 40000 
cells; in addition, material only controls were also 
cultured under the same culture conditions.
Cell source and culture
Primary ACL derived TCs were isolated from ACL tissue 
obtained from full-knee prosthesis surgery (ethical 
approval was obtained from the local committee: KEK 
registration 22-12-13). Primary TCs were isolated by 
cutting the tissue in smaller pieces of approximately 4 
mm3 pieces, then washed in phosphate buffered saline 
(PBS) twice and digested overnight in collagenase 
2 (Worthington, London, United Kingdom) at 37 ℃, 
under constant shaking at 10 RPM. The released cells 
were filtered with a 100 µm cell strainer (BD Falcon, 
Switzerland) and seeded at a density of 1000 cells/
cm2 for monolayer expansion in HG-DMEM + 10% 
FCS. With written consent human bone marrow was 
obtained from patients ages 55-84 undergoing hip or 
spine surgery. The procedure was approved by the 
Ethics Office of the Canton of Bern (KEK # 187/10), 
all patients gave their informed consent prior to their 
inclusion in the study. Human MSCs were amplified 
from the mononuclear cell fraction after density gradient 
centrifugation (Histopaque-1077, Sigma) by selection 
for plastic adherence for 2-3 passages. The MSCs were 
expanded using α-Minimal Essential Medium (α-MEM) 
with 10% FCS, 100 µg/mL penicillin, 100 UI/mL 
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Figure 1  Dynamic intraligamentary stabilization screw called Ligamys© (Mathys, inc. Bettlach, Switzerland). A: Close-up of the outside of the screw made of 
titanium and illustrating with a mounted lace which mimics the polyethylene string that is mounted in the real surgery to stabilize the knee joint in case of an ACL rupture; 
B: Inside of the dynamic fixation screw with the spring that takes the dynamic load of the ACL and stabilizes the joint; C: Illustration of the exact position of the dynamic 
intraligamentary stabilization in situ in the knee joint. ACL:  Anterior cruciate ligament.
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inserts allowed us to evaluate changes in MSCs gene 
expression in co-culture. Separating the MSCs and TCs 
cultures with inserts made it possible to attribute the 
relative gene expression results of cells in co-culture 
to the correct cell type. The pore size was chosen to 
facilitate cell-cell contact between the two cell types, 
without allowing for cell migration between the two cell 
populations. This setup allowed us to observe whether 
cell-cell contact permits differentiation of MSCs into TCs 
phenotype. 
The co-culture for the gene expression analysis 
was set up as follows: culture inserts were seeded on 
the bottom with 100000 MSCs. Two hundred microlitre 
HG-DMEM medium with 10% FCS and 1 × P/S was 
added to the layer of MSCs. The inserts, bottom side 
facing up, were placed on a petri dish, covered with a 
beaker and placed in a 37 ℃ incubator for 1 h. Within 
this timeframe, the MSCs adhered to the insert, as 
has been shown in previous studies by our group[18]. 
Subsequently, the other side of the insert was also 
seeded with the same number of TCs.
Resazurin sodium salt metabolic cell activity assay
Patches were incubated at 37 ℃ on a shaker for 5 h 
with resazurin red solution to measure mitochondrial 
activity as described in[19]. Resazurin is a nontoxic, 
cell-permeable compound that is blue in color and 
virtually non-fluorescent. Upon entry into cells, 
resazurin is reduced to resorufin, which emits very 
bright red fluorescence. The amount of fluorescence or 
absorbance is proportional to the number of living cells 
(the linearity of transformation was evaluated based on 
primary cells) and corresponds to the cell’s metabolic 
activity. The amount of fluorescence was monitored 
with a Softmax® M5 Pro Multi wavelength fluorescence 
reader (Molecular Devices, distributed by Bucher 
Biotec, Switzerland) at excitation 547 nm and emission 
wavelength 582 nm.
Quantification of DNA, glycosaminoglycan and HYP 
content
For biochemical analysis, dry-weight of each sample 
was measured and then each sample was digested 
with papain. We used the dimethylmethylene blue 
(DMMB) dye method to analyze the digested samples 
for sulphated glycosaminoglycans (GAGs), using bovine 
chondroitin sulfate as standard. Total collagen content 
was determined based on the hydroxy-proline content 
after acid hydrolysis and reaction with p-dimethyl-
amino-benz-aldehyde and chloramine-T[20,21].
RT-PCR
All samples were frozen down on day 0 and day 7 of 
each experiment, except for two samples collected 
during the pilot experiment, which were collected on 
day 8 (NC patch with TCs and NC patch with MSCs). 
RNA extraction was performed with TRI reagent 
[Molecular Research Center (MRC), Cincinnati, 
streptomycin, and 5 ng/mL bFGF-2[17].
Scaffold seeding
Scaffolds that were seeded contained either a single cell 
type-human MSCs or human TCs- or a combination of 
both cell types (Figure 3). For the samples containing 
co-cultures, the two cell types were mixed in a ratio 
of 1:1 prior to seeding; recent literature demonstrates 
that this provides the most effective ratio[16]. All patches 
were placed in 12 well plates, and the samples were 
incubated for approximately one hour prior to adding 2 
mL medium to each well, in order to give the cells time 
to adhere to the patch.
Monolayer cultures
In addition to the scaffold samples, we also grew 
monolayer cell cultures as well as co-cultures using 
translucent inserts (Falcon, 6 well cell culture inserts, 0.4 
μm PET high density pores, Falcon™, BD Biosciences, 
Allschwil) in 6 well plates (Falcon™). The single cell 
population monolayer controls served as reference 
samples for the real-time PCR results, while the 
524 March 26, 2015|Volume 7|Issue 2|WJSC|www.wjgnet.com
Primary ACL tenocytes
Collagen sheet
Mesenchymal stem cells
Wrapped around 
ACL
Ruptured ACL DIS fixated rupture wrapped 
in collagen patch
A
B C
Figure 2  Overview of current regenerative approaches to improve anterior 
cruciate ligament rupture treatment in combination of the dynamic 
intraligamentary stabilization approach. A: First mesenchymal stem cells 
and/or primary ACL-tenocytes are pre-seeded on collagen patches (shown in 
blue); B: Ruptured ACL; C: DIS approach takes over major mechanical load and 
stabilizes the knee, whereas collagen patch wrapped around the ACL provides an 
ideal solution to improve clinical outcome. ACL: Anterior cruciate ligament; DIS: 
Dynamic intraligamentary stabilization.
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MA, United States], polyacrylcarrier (MRC), 100% 
molecular grade ethanol, 1-bromo-3-chloropropane 
(BCP, Sigma Aldrich), GenElute miniprep kit, and the 
AMP-D1 DNase I Kit which contains both DNase I and 
10 × DNase Digest Buffer (all Sigma Aldrich). The 
same process was followed for all samples, except 
that the scaffold samples were subject to an additional 
step, since those samples had been snap frozen in 
liquid nitrogen on day 7 of the experiments and placed 
in -80 ℃ without any RNA protective solution. In 
order to perform RNA extraction on those samples, 
the scaffold samples were first ground using a mortar 
pre-cooled with liquid nitrogen, then immediately 
placed in a solution containing 1 mL TRI and 5 µL 
polyacrylcarrier. The samples were then centrifuged 
at 16000 g to separate the scaffold debris from the 
solution. cDNA synthesis was performed with the 
iScript cDNA synthesis kit (Bio-Rad Laboratories, 
Cressier, Switzerland). For each sample, 20 µL reaction 
mix was set up containing 10 μL RNA template (about 
0.5-1 µg total RNA), 4 µL 5 × iScript Reaction Mix, 1 
µL iScript reverse transcriptase and 5 µL nuclease-free 
water. After the incubation, the cDNA samples were 
diluted with 40 µL 1 × TE Buffer.
We evaluated the relative gene expression for the 
genes we were interested in using human primers (all 
Microsynth, Balgach, Switzerland; see Table 1 for a 
detailed list of primers). Separate forward and reverse 
primers were used to set up the reaction mix, which 
also contained iQ SYBR Green Supermix2X (Bio-Rad) 
and RNAse free water. We tested ligament fibroblast 
markers including scleraxis, tenomodulin, tenascin-C, 
collagen Ⅰ and Ⅲ[6,22]. In addition, we tested for gene 
expression of two matrix metalloproteinases (MMPs, 
enzymes which regulate matrix turnover) MMP3 and 
13, aggrecan and collagen type Ⅱ. MMP3 (stromelysin 
1) and MMP13 (collagenase 3) break down collagen 
and proteoglycans quickly and are known to play a role 
in ligament remodeling[23]. Collagen Ⅱ was used to test 
that the cells did not differentiate into chondrocyte-
like cells. There has been some evidence of increased 
amounts of proteoglycans in pathological tendons; 
therefore, gene expression of aggrecan was also 
evaluated[22]. To calculate relative gene expression, 
the Livak method (2-∆∆Ct)[24] was used, which makes 
use of both a calibrator sample and a normalizing 
reference gene; we applied 18S (ribosomal RNA) as 
the reference gene for all samples[25]. Relative gene 
expression levels for samples were calibrated to day 0 
reference samples. Day 7 TCs samples were compared 
relative to TCs at day 0; day 7 MSCs samples were 
compared relative to MSCs at day 0 (i.e., expression = 
1.0). 
Microscopy techniques
Confocal laser scanning microscopy (cLSM) was 
used to confirm visually that cells are able to adhere 
and proliferate on the scaffolds in the first two 
experiments. Samples for the cLSM were stained using 
Vybrant membrane tracker dyes DiO (DiO = green, 
for MSCs) and DiL (DiL = red, for TCs) (both Molecular 
Probes, Life Technologies, Basel, Switzerland); these 
dyes are lipophilic carbocyanines, which integrate into 
the membrane[26]. In addition, we also imaged the cells 
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Monolayer set-up
Monolayer TC Monolayer MSC Co-culture 1:1
3D culture set-up
3D collagen patch 8 mm TC 3D collagen patch 8 mm MSC 3D collagen patch 8 mm TC:MSC 1:1
Control: material only
Figure 3  Experimental design of in vitro testing of cyto-compatibility. All monolayer and collagen patch cultures were run for 7 d under standard culture conditions 
(37 ℃ at 100% humidity and 5% CO2) in high glucose Dulbecco’s Modified Eagle Medium and 10% fetal calf serum. MSC: Mesenchymal stem cell; TC: Tenocyte.
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on both sides of the culture inserts. This allowed us 
to confirm that the cells adhered to both sides of the 
culture insert and could therefore be evaluated with 
real-time PCR.
Further, additional samples were prepared during 
one experiment to be processed with scanning 
electron microscopy (SEM), as this method permits 
visualization of 3D structures on a very small scale. This 
technique also allowed us to see how the cells attach 
to the scaffold, as well as provided a more detailed 
visualization of the scaffolds themselves. On day 7, the 
samples were first washed with PBS to remove traces 
of serum, then fixed with 2.5% glutar-aldehyde. On 
the day of SEM sample preparation, the specimen were 
again washed with PBS prior to following a dehydration 
protocol using an alcohol series of increasing 
concentration, i.e., 50%, 70%, 80%, 90% and 2 × 
100%, with incubation periods of 10 min. Subsequently, 
the specimen were critical point–dried in a Bal-Tec CPD 
030 (BalTec inc., Balzers, Liechtenstein) and sputtered 
with approximately 10 nm (30 mA for 30 s at 50 mm 
working distance), producing a 10 nm gold layer in a 
SCD 004 (BalTec inc.). Samples were then stored in an 
exsiccator until examination at 5 kV accelerating voltage 
in a Zeiss scanning electron microscope DSM 982 (Carl 
Zeiss, Jena, Germany). 
Statistical analysis
Data were analyzed using the Kruskal-Wallis test 
unless otherwise noted, followed by Dunn’s multiple 
comparisons test using the PRISM software package 
(GraphPad, La Jolla, United States, version 6.0e). RT-
PCR data was tested using a t-test statistic and mean 
gene expression was tested if significantly different 
from a hypothetical value of 1.0. A significance value 
of P < 0.05 was specified to be significant. Where 
applicable groups were tested in 2-way ANOVA for 
treatment and culture time, multiple comparisons were 
then performed using Bonferroni’s multiple testing. 
The statistics was checked by a biostatistics expert.
RESULTS
The experiments were meant to provide initial insight 
into whether NC and CG collagen patches, which are 
currently being used in cartilage repair, are suitable 
for ACL repair. Thus, adherence and proliferation of 
cells was tested, as well as the collagen deposition and 
differentiation potential of cells.
Adherence, proliferation and matrix changes
CLSM and SEM imaging and the metabolic cell activity 
assay confirmed that both cell types, TCs and MSCs, 
adhere on the substrate and seem to proliferate on 
both patch types (Figure 4). The images seem to 
show, however, that MSCs decreased in cell number 
after 7 d. 
Noteworthy, DNA content (Hoechst) of collagen 
scaffolds contained a relatively high amount of 
porcine/bovine DNA (Figure 5), which was confirmed 
by DNAse digestion (data not shown). There was no 
significant change in DNA content among the groups 
over the 7-d culture period. The metabolic cell activity 
assay (see Figure 6) revealed increased cell activity 
on day 7 vs day 1 for all cell treatment groups, and 
a slightly higher absolute level of cell activity for all 
CG samples versus NC patches on a given day. The 
relative increase in cell activity level from day 1 to day 
7 in both patch types was similar (Figure 6).
The non-parametric Kruskal-Wallis tests showed 
that cell type did not have a significant impact on the 
relative change in metabolic activity for either of the 
two patch types (Figure 6). Furthermore, we found no 
significant differences between NC and CG samples in 
terms of the relative changes in metabolic cell activity 
between the two patch types. While both patch types 
also showed an increase in absolute cell activity, as 
measured in RFUs, from day 1 to day 7 for every cell 
type, this trend was not significant for NC patches, 
but significant at an overall level for CG patches (P 
= 0.0298, n = 4). Dunn’s multiple comparisons test 
for CG however revealed no significant P values for 
individual treatment groups (TCs, MSCs, premix) with 
different treatment lengths (Figure 6). However, after 
testing for 2-way ANOVA for time and treatment we 
found a significant effect (P = 0.0001) of culture time 
and found that activity increased over time for TCs and 
premixes (P = 0.0237 and P = 0.0120, respectively) 
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Table 1  Real-time polymerase chain reaction primers used for real-time polymerase chain reaction
Abbreviation Gene name Forward Reverse
18S 18S Ribosomal RNA CGA TGC GGC GGC GTT ATT C TCT GTC AAT CCT GTC CGT GTC C
HsACAN Core protein CAT CAC TGC AGC TGT CAC AGC AGC ACT ACC TCC TTC
Hs_col1 Collagen 1 A2 GTG GCA GTG ATG GAA GTG CAC CAG TAA GGC CGT TTG
Hs_col2 Collagen 2 A1 AGCAAGAGCAAGGAGAAG GGGAGCCAGATTGTCATC
Hs_col3 Collagen 3 A1 GTG AGC CTG GTA AGA ATG G CCT GGA ACA CCT GGA ATA C
Hs_TNC Tenascin C CAC GCT GAG GTT GAT GTT C GTT GAT GGT CGC TGG ATT G
Hs_SCX Scleraxis A CAC CAA CAG CGT GAA CAC GCA GCG TCT CAA TCT TGG A
Hs_TNMD Tenomodulin ACA AGC AAG TGA GGA AGA A GAC GGC AGT AAA TAC AAC AAT
Hs_MMP13 Collagenase 3 AGT GGT GGT GAT GAA GAT CTA AGG TGT TAT CGT CAA GTT
Hs_MMP3 Matrix metallopeptidase 3 CAA GGC ATA GAG ACA ACA TAG A GCA CAG CAA CAG TAG GAT
All primers were run at 61 ℃ Ta (annealing temperature) and a two-step protocol (95 ℃ for 10 s and 61 ℃ for 30 s) and 45 cycles.
Gantenbein B et al . Mesenchymal stem cells for ACL repair
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100 µm
(Figure 6).
Previous studies suggested that pathologic tendons 
exhibit higher GAG content[22]. We, therefore, measured 
GAG content on day 1 and day 7 (n = 3). In all samples, 
there was a decrease in the amount of GAG from day 1 
to day 7 (µg per mg of dry-weight, corrected for controls 
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Figure 4  Z-projections of confocal laser scanning microscope images of 200 µm 3D-stacks through the collagen patches of mesenchymal stem cells and 
anterior cruciate ligament-derived tenocytes on day 1 and after 7 d of culture on Novocart™ and Chondro-Gide™. Cells were stained with Vybrant™ DiO (DiO 
= green, MSCs) and DiL membrane tracker dyes (DiL = red, TCs) prior to seeding. Last row are scanning electron microscope pictures of the cell-seeded scaffolds 
after 7 d of culture showing adherence and shape of the MSCs and tenocytes on the scaffolds. Note that for Chondro-Gide™ patches these are only images from TCs 
seeded scaffolds. For the Novocart™ patches the right most image is from an experiment containing a premix of cells, and the left most and center SEM image are from 
experiments with MSCs seeded scaffolds. MSC: Mesenchymal stem cell; ACL-TC: Anterior cruciate ligament-derived tenocyte; SEM: Scanning electron microscope.
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Figure 5  DNA content of collagen patches. DNA 
content of collagen patches seeded with anterior cruciate 
ligament-derived tenocytes (TCs) and/or MSCs on 
Novocart™ and Chondro-Gide™ normalized per dry 
weight per carrier for the collagen patches for day 1 and 
day 7 of the experiment (values are means ± SEM, n = 3 
experiments for day 1, 4 experiments for day 7). Note the 
large amount of DNA present in material controls. MSCs: 
Mesenchymal stem cells.
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Figure 6  Mitochondrial cell activity. Mitochondrial cell activity measured by resazurin red assay of collagen patches seeded with anterior cruciate ligament-derived 
tenocytes (TCs) and/or MSC on NC and CG normalized per dry weight carrier for the collagen patches for day 1 and day 7 of the experiment (values are means ± SEM, n 
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using day 7 sample with no cells as a baseline for all 
samples). No significant difference was found between 
the two patch types or cell types in terms of the relative 
changes of GAG measured (Figure 7A).
Hydroxy-proline (HYP) levels were measured in 
order to assess collagen deposition of the different cell 
types on the scaffold (Figure 7B). Data revealed no 
significant change in HYP over time. In line with the 
other analyses, the different cell types were not found 
to have a significant effect on the percentage change 
of HYP measured, neither for NC patches nor for CG 
patches. Also, the Kruskal-Wallis test did not reveal 
a significant difference between the two patch types. 
However, when the ratio of HYP/GAG was considered, 
the 2-way ANOVA for scaffold and cell treatment 
showed a significant relative change for the Premix 
group (P = 0.005) (Figure 7C). 
Both cell types (TCs and MSCs) were analyzed 
individually with regards to the effect of different 
substrates (NC patch, CG patch, inserts or just well 
plates) on the relative gene expression for the genes 
of interest. A summary of the relative gene expression 
measurements is shown in Figure 8. 
Relative gene expression revealed a significant 
down-regulation of TNMD for TCs grown on NC scaffolds 
(P < 0.0001) and for col2 in TCs grown on culture 
inserts (P = 0.0121) relative to day 0 controls (Figure 
8A). Monolayer MSCs significantly down-regulated 
MMP3 (P = 0.0065) after 7 d of culture, whereas MSCs 
grown on culture inserts significantly up-regulated col3 
(P = 0.006) and down-regulated MMP3 (P = 0.0065).
DISCUSSION
TCs gene expression
In line with expectations, both patch types showed a 
slight up-regulation of collagen Ⅰ gene expression for 
TCs in comparison to TCs grown in monolayers (Figure 
8). Scleraxis expression trended up on patches vs d0 
but was in line with monolayer results (Figure 8). At 
the same time, both patch types did not result in a 
significant up-regulation of collagen Ⅱ or aggrecan, 
compared to monolayer (Figure 8). These factors 
suggest that the cells did not differentiate into cells of a 
chondrocyte phenotype. Based on the non-parametric 
Kruskal-Wallis test statistic, the differences in relative 
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gene expression between TCs cultured on NC or CG 
patches or in monolayers are not significant, which 
is in line with our initial hypothesis. We did observe 
significant changes of relative gene expression when 
tested with one-sample t-test. While gene expression 
levels for TCs on NC patches were not vastly different 
from those cultured on CG or in monolayers, TCs 
grown on NC significantly expressed less tenomodulin 
D (TNMD) and do seem to express slightly lower 
levels for the ligament markers collagen type 3 (col3), 
tenascin- C (TNC) and scleraxis (SCX) relative to those 
two substrates (see Figure 8A).
At first sight, especially when considering these 
data in light of the metabolic cell activity results, 
it may seem that the CG patches provide a better 
environment for TCs. The metabolic cell activity 
measurements showed that cells grown on CG 
patches vs NC patches exhibited a slightly higher (yet 
statistically insignificant) absolute cell activity on any 
given measurement day, as well as a somewhat higher 
relative increase in cell activity from day 1 to day 7 
of the experiments. However, this aspect needs to be 
carefully examined further.
It is possible that the culture time was not long 
enough to clearly discern significant differences 
between patch types. MSCs and TCs were cultured for 
up to 28 d and checked for cell adherence with the use 
of CLSM and the cell tracker dyes. Studies related to 
osteogenesis show that osteogenic differentiation of 
MSCs can take up to four weeks, with an initial early 
differentiation phase taking place between day 5 and 
day 14[27]. Conversely, it has also been shown that 
MSCs can show signs of differentiation into tenogenic 
phenotype after as little as seven days[28]. It is also 
possible that the cells on the NC scaffolds first partially 
de-differentiated. The down-regulation of tenomodulin 
(TNMD) has been observed for cells that were cultured 
two-dimensionally[29]. Since we observed a stronger 
down-regulation for cells cultured on NC than in 
monolayers, this may be interpreted as an indication 
of de-differentiation. This de-differentiation has been 
previously observed in monolayers as well as in organ 
cultures[15].
Furthermore, scleraxis has been shown to modulate 
TNMD expression, such that the up-regulation of 
TNMD occurred several days after an up-regulation in 
scleraxis was observed[30].
It is known that the structure of scaffolds can 
impact the cell morphology; ACL fibroblasts for 
instance orient parallel to collagen fibers. Cell shape 
A
B
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Figure 8  Relative gene expression of major extracellular 
matrix genes important for anterior cruciate ligament repair 
and mesenchymal stem cells differentiation grown on 3D 
collagen patches, i.e., Novocart™ and ChondroGide™. A: Gene 
expression of anterior cruciate ligament-derived tenocytes (TCs) 
relative to day 0 TCs; B: Gene expression of bone marrow-derived 
MSCs relative to day 0 MSCs (values are means ± SEM, n = 4 
experiments for CG and n = 5 for NC). MSC: Mesenchymal stem 
cell; NC: Novocart™; CG: ChondroGide™; SEM: Scanning electron 
microscope.
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on the other hand can impact cell differentiation[30,31]. 
In fact, both patches were primarily constructed 
for use with chondrocytes. The manufacturer of NC 
patches clearly states that the patches are meant 
to induce a spherical morphology, which describes a 
chondrocyte phenotype. However, with SEM imaging 
we observed flat networks covering the NC patches. 
This observation was in line with the gene expression 
results, which demonstrate that the cells do not up-
regulate genes, which are typical for chondrocyte 
phenotype. It would be interesting to re-evaluate all 
variables in experiments running for 14 or 21 d, to test 
whether this still holds true.
MSCs phenotype
MSCs cultured on patches showed a trend towards 
up-regulation of ligament markers versus MSCs 
monolayers, particularly on NC scaffolds. For instance, 
collagen Ⅲ tended to be up-regulated on NC, with a 
more inconsistent expression for MSCs on CG (Figure 
8). Scleraxis tended to be higher expressed on both 
patches compared to MSCs cultured in monolayers or 
on inserts (Figure 8). These results seem to indicate 
that MSCs are developing into a TCs phenotype on the 
patches. MSCs cultured with TCs, however, consistently 
up-regulated col 3 expression, a sign for early 
differentiation of the MSCs towards a more TC-like 
phenotype. Again, additional time might be required 
in order to draw more conclusive insights about the 
potential for MSCs to differentiate on the various 
substrates. However, interpreting the results of the RT-
PCR data demonstrating a significant increase of col 
3 in presence of TCs on culture inserts together with 
the significantly increased HYP/GAG ratio of “premix” 
of TCs and MSCs on the 3D patches (Figure 7C) could 
be interpreted as an early differentiation of MSCs 
shutting down gene expression of GAG and increasing 
collagen expression. A study related to tenogenic 
differentiation of rat MSCs showed that a significant 
change in expression levels for some ligament markers 
could already be detected after 7 d (tenascin-C as well 
as scleraxis); however, other markers were not up-
regulated until a few days later (collagen Ⅰ and Ⅲ)[28].
There were some inherent limitations in the cell 
types used in our study. Cells had to be obtained from 
patients whom may already exhibit certain morbidities. 
TCs were provided from patients undergoing knee 
surgeries– either total knee arthroplasties or ACL 
reconstruction. Patient number 67, for instance, 
underwent ACL reconstruction due to a traumatic 
rupture, where the stumps were intra-operatively 
removed prior to graft insertion. It is possible that 
the cells cultured from these stumps may naturally 
exhibit slightly different characteristics, a topic that 
should be explored further. Moreover, it is also possible 
that the age of the donor plays a role in terms of the 
differentiation potential of the MSCs.
In this respect, it is also worth mentioning the 
existence of native ACL-derived autochthonous 
stem cells (ACL-SC), which already may exist in the 
tissue[32]. Zhang et al[32] described the isolation and 
characterization of such plastic-adherent cells, which 
possess stem cell characteristic surface markers 
from healthy tissue samples. However, it is unknown 
whether these cells might still be present in more 
degenerated human tissue as analyzed in this study. 
An additional aspect that should be considered is the 
donor characteristics of cells (Table 2). In four out 
of five trials we had male MSC donors and in all five 
experiments, we had female TC donors (Table 2). 
The gender and age of the donors may have a hidden 
effect on the outcomes, including proliferation rates or 
differentiation ability. However, current evidence of the 
impact of gender and age is inconclusive[33,34].
Imaging analysis 
Confocal laser scanning microscopy (CLSM) images of 
CG patches showed less MSCs than TCs, both in the 
single cell culture of MSCs as well as when cultured 
together with TCs. The MSCs appear in a rounded 
shape in the CLSM images, as opposed to the TCs, 
which have a more elongated appearance. This is in 
line with the SEM results for the CG patches, on which 
we found rather roundish morphologies.
There seems a conflict in the data that the cell 
density on CG patches was decreasing for MSCs (Figure 
4 lower panel) but DNA content (Figure 5) and cell 
activity (Figure 6) showed a steady-state and a trend 
of increased activity, respectively. We interpret this as 
a donor-specific phenomenon in the CLSM data.
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Table 2  Summary of the donor tissue that was used to harvest and expand primary cells, i.e. , bone marrow derived mesenchymal 
stem cells and anterior cruciate ligament-derived tenocytes and stage of passage for 3D culture experiment
MSCs donor characteristics TCs donor characteristics
Experiment ID Passage Donor gender Donor age Source Experiment ID Passage Donor gender Donor age Source
1 62 1 m 75 Lumbar 1 66 1 f 62 ACL
2 62 2 m 75 Lumbar 2 66 2 f 62 ACL
3 65 1 f 84 Lower limbs 3 67 1 f 38 ACL
4 47 2 m 64 Thoracal 4 67 2 f 38 ACL
5 48 2 m 55 Thoracal 5 70 1 f 74 ACL
MSC: Mesenchymal stem cell; TC: Tenocyte; ACL: Anterior cruciate ligament.
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Extracellular matrix and collagen patch environment
GAG and HYP values were also corrected for control 
values, as we registered significant amounts of initial 
GAG and HYP in our controls (Figure 7A and 7B), 
which was expected considering that collagen patches 
consist primarily of collagen 1 and 3. Correcting for 
the controls, we see a decrease in GAG per mg of dry-
weight. This suggests that the MSCs are changing in 
phenotype and possibly produce less GAG over time if 
in direct 1:1 co-culture. Interestingly, comparing the 
relative change of the HYP/GAG ratio of day 7 relative 
to day 1 showed a significant effect of “premix” cells 
but there was no effect of the differences between the 
two scaffolds (Figure 7). The effect of cells was highly 
significant in the 2-way ANOVA (P = 0.005, Figure 
7). Thus, premix of cells shifted the ratio between 
HYP/GAG towards lower production of GAG and slight 
increase of HYP. 
In conclusion, the results of these 3D cell culture 
experiments demonstrate the potential of collagen 
patches for ACL repair[4]. Using biochemical and 
imaging methods, we were able to demonstrate that 
primary TCs and MSCs can both be grown on the NC 
and CG patches, which were originally designed to 
induce a chondrogenic phenotype. Both TCs and MSCs 
adhere to and proliferate on the patches. Moreover, 
MSCs seem to show a tenogenic differentiation 
potential on these scaffolds as indicated by the 
significant increase of collagen type 3. Future work 
might consider the importance of alternative stimuli to 
accelerate healing such as the application of platelet 
rich plasma (PRP) or platelet rich fibrin (PRF). The 
problem with ACL-derived TCs and MSCs, which have 
to be expanded first ex vivo on plastics, is their clinical 
approval. With PRP on the other hand are unsolved 
issues about the reproducibility and the ideal dose of 
platelet concentrations[35,36].
Further studies should be performed to evaluate 
additional aspects. First of all, it would be beneficial to 
run the experiments with a longer culture time. This 
would permit a more in depth analysis of the induced 
cell morphologies on the different patches, which 
could alter the survivability of the cells as well as the 
differentiation potential. Additionally, it would allow us 
to observe whether this changes the gene expression 
profile of the cells. It is also likely that longer culturing 
duration would lead to more pronounced differences 
between cell and patch types and be able to further 
support the trends we have observed so far.
Furthermore, studies should also be performed 
using mechanical loading. It has been shown that 
mechanical strain induces MSCs to differentiate into 
a TCs phenotype[37,38]. It would be interesting to see 
whether the cells respond differently on the two 
patch types, subjected to equal parameters. Also, 
the mechanical properties of a scaffold are known 
to impact cell differentiation. In fact, several prior 
attempts at ligament or tendon repair have resulted in 
ectopic bone formation[30]. Thus, further experiments 
testing the impact of the mechanical properties 
would be helpful in evaluating the full potential of 
these patches. However, in these studies, it would be 
crucial also to look at bone-specific markers such as 
osteocalcin[30].
In conclusion, while certain aspects should be 
examined in more depth, the use of collagen scaffolds 
for ACL regeneration is promising[4]. The usage of a 
biological ACL repair model including collagen patches 
in a non-loading repair model seems a genius option 
to improve healing. What remains to be shown is 
whether mechanical loading improves the healing 
process or whether platelet rich fibrin PRF or PRP 
might be another option to be included at the site of 
rupture for the healing or whether it might be even 
hindering the healing process as has been recently 
proposed[35,36,39,40]. 
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Current treatment options for non-fusions of ruptured ACLs are very limited.
Research frontiers 
ACL injury is a common disease and the repair of ACL remains a challenge due 
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techniques for ACL repair, an ideal biological scaffold for ACL reconstruction is 
needed to improve clinical outcome, especially in the case of non-unions.
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not much known how cell therapy could accelerate and improve healing for ACL 
ruptures in combination with a recently developed dynamic anchoring technique 
called Ligamys©. The combination of regenerative approaches involving TCs 
and MSCs transplantation along with commercially available FDA-approved 
collagen patches seems a straightforward approach, as the membrane is highly 
biocompatible and does not carry the mechanical force.
Applications
Cyto-compatibility for the collagen patches is a tool to explain good clinical 
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marrow mesenchymal stem cells or primary tenocytes for possible anterior 
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as a bilayer membrane. Novocart is a biphasic, three-dimensional collagen-based 
matrix from bovine. Both collagen sponges have been used for cartilage repair. 
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to its limited self regenerative ability. Despite of the progression of reconstructive 
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the patches of collagen may be useful for anterior cruciate ligament repair.
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